Er-Kim CEO Cem Zorlular Recognized as a Patient Champion on the 2024 PharmaVoice 100
October 15, 2024 07:00 ET
|
Er-Kim
Cem Zorlular, CEO of Er-Kim recognized as a patient champion in this year's PharmaVoice100
Avalyn CEO Lyn Baranowski Named a PharmaVoice 100 Honoree
October 08, 2024 09:00 ET
|
Avalyn Pharma Inc.
CAMBRIDGE, Mass., Oct. 08, 2024 (GLOBE NEWSWIRE) -- Avalyn Pharma Inc., a clinical-stage biopharmaceutical company focused on development of inhaled therapies for the treatment of life-threatening...
Parexel’s Teri Karcher Named to 2024 PharmaVoice 100
October 08, 2024 08:55 ET
|
Parexel International LLC
Chief Drug Development Officer and Executive Vice President, Head of Launch Excellence recognized for pioneering leadership in drug development DURHAM, N.C., Oct. 08, 2024 (GLOBE NEWSWIRE) --...
Global Active Pharmaceutical Ingredients (APIs) Market Analysis, 2024-2029, Featuring Profiles of 32+ Major Players, Including Pfizer, Teva Pharmaceutical Industries, GSK, Sanofi, and Viatris
June 13, 2024 06:35 ET
|
Research and Markets
Dublin, June 13, 2024 (GLOBE NEWSWIRE) -- The "Global Active Pharmaceutical Ingredient Market by Type (Innovative, Generic), Manufacturer (Captive, Merchant), Synthesis (Synthetic, Biotech),...
Park National Corporation welcomes Kelly Gratz and Karen Morrison to Board of Directors
May 21, 2024 16:15 ET
|
Park National Bank
NEWARK, Ohio, May 21, 2024 (GLOBE NEWSWIRE) -- Park National Corporation’s (NYSE American: PRK) (Park) board of directors announced today that they elected Karen Morrison and Kelly Gratz to serve as...
XORTX Welcomes New Member to the Board of Directors
April 08, 2024 07:30 ET
|
XORTX Therapeutics Inc.
CALGARY, Alberta, April 08, 2024 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. ("XORTX" or the “Company”) (NASDAQ: XRTX | TSXV: XRTX | Frankfurt: ANUA WKN: A3UNZ), a late-stage clinical pharmaceutical...
Aquestive Therapeutics Strengthens Board of Directors with Experienced Biotech Executive
April 01, 2024 08:00 ET
|
Aquestive Therapeutics, Inc.
WARREN, N.J., April 01, 2024 (GLOBE NEWSWIRE) -- Aquestive Therapeutics, Inc. (NASDAQ: AQST) (“Aquestive” or the “Company”), a pharmaceutical company advancing medicines to bring meaningful...
PepGen Announces Appointment of Howard Mayer, M.D. to Board of Directors
November 15, 2023 08:00 ET
|
PepGen Inc.
BOSTON, Nov. 15, 2023 (GLOBE NEWSWIRE) -- PepGen Inc. (Nasdaq: PEPG), a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapies with the goal of transforming...
Parexel’s Amy McKee, M.D. Named to 2023 PharmaVoice 100
September 20, 2023 08:55 ET
|
Parexel International LLC
DURHAM, N.C., Sept. 20, 2023 (GLOBE NEWSWIRE) -- Parexel, one of the world’s largest clinical research organizations (CROs) providing the full range of Phase I to IV clinical development services,...
Science 37 Chief Delivery Officer, Darcy Forman, Named to Prestigious PharmaVoice 100 List
September 20, 2023 07:59 ET
|
Science 37, Inc.
RESEARCH TRIANGLE PARK, N.C., Sept. 20, 2023 (GLOBE NEWSWIRE) -- Science 37 Holdings, Inc. (Nasdaq: SNCE), the clinical research industry-leading Metasite™, today announced that its Chief Delivery...